EBERINI, IVANO
EBERINI, IVANO
Dipartimento di Scienze Farmacologiche e Biomolecolari Rodolfo Paoletti
Modulating mAbs Function through Glycosylation and Isotype: A Molecular Dynamics Perspective
2026 D. Bianchi, S. Saporiti, O. Ben Mariem, F. Centola, I. Eberini
Tavola rotonda. Il confronto tra gli stakeholder
2026 P. Blasi, I. Eberini, F. Russo, S. Mallamaci, A. Mandelli, M. Pellegrini Calace, G. Vistoli
Mechanistic Insights into Lysine Cyclodeaminase Catalysis
2026 Y. Wei, U. Guerrini, I. Eberini
Targeting Monocarboxylate Transporters to Overcome Metabolic Plasticity in Melanoma
2026 O. Ben Mariem, F. Strada, D. Bianchi, L. Palazzolo, F. Fontana, I. Eberini
Structural determinants of IgG1-FcγRIIIa interaction: a comprehensive computational study
2026 D. Bianchi, S. Saporiti, W. Palinsky, O. Ben Mariem, U. Guerrini, M. Rossi, F. Centola, I. Eberini
Computational dissection of the cooperative effects of Fc glycosylation and light chain isotype on IgG1::FcγRIIIa recognition
2026 D. Bianchi, S. Saporiti, W. Palinsky, O. Ben Mariem, U. Guerrini, M. Rossi, F. Centola, I. Eberini
Antigen binding triggers long-range conformational changes in monoclonal antibodies
2026 D. Bianchi, S. Saporiti, W. Palinsky, O. Ben Mariem, M. Rossi, I. Eberini, F. Centola
Approccio in silico per la valutazione dei singoli composti
2026 L. Palazzolo, O. Ben Mariem, I. Eberini
Structure-based modeling reveals molecular basis for CYP153A6’s novel activity toward toluene derivatives
2026 Y. Wei, S. Donzella, S. Foiadelli, F. Molinari, U. Guerrini, I. Eberini
In silico screening and preclinical validation identify bavisant as a therapeutic candidate for multiple sclerosis
2026 N. Gacem, S. Bezukladova, F. Windener, T. Karam, L. Ottoboni, E. Brambilla, F. Ruffini, K. Soman, B. Garcia-Diaz, M.J.F. Levy, Q. Cui, A. Formato, C. Deboux, J. Chazot, R. Panic, S. Albrecht, E.N. Yilmaz, R.G. González, I. Eberini, S. Olla, A. Bresciani, N. Goebels, F. Zipp, C. Agresti, J. Antel, A.B. Evercooren, T. Kuhlmann, S.E. Baranzini, P. Panina-Bordignon, B. Nait-Oumesmar, G. Martino
Predicting acute developmental toxicity of chemicals in embryos of the African clawed frog (Xenopus laevis): Calibration and validation of regression-based quantitative structure activity relationship models for hazard assessment of chemicals in anuran amphibians
2026 C. Novello, M.R. Di Nicola, J.L. Cm Dorne, E. Colombo, E.L. Viganò, M.E. Ortiz-Santaliestra, N. Kramer, E. Carnesecchi, A.M. Steinbach, I. Eberini, A. Williams, E. Benfenati, A. Roncaglioni
Structure-Guided Prioritization and Synthesis of New Ligands for GPR17 Receptor
2026 M. Rabuffetti, F. Rinaldi, L. Palazzolo, D. Bianchi, M.L. Trincavelli, I. Balloni, S. Daniele, S. Capaldi, G. Speranza, I. Eberini, E. Calleri
Duloxetine ameliorates cerebral ischemic injury by inhibiting autophagy
2026 A. Viotti, C. Molinaro, J. Perego, A. Fossaghi, C. Parravicini, E. Lauranzano, A. Borreca, M. Piccoli, L. Anastasia, S. Manenti, A. Finardi, A. Mandelli, M. Matteoli, I. Eberini, P. Panina, G. Martino, L. Muzio
Identification of neuronatin as a SERCA2b regulin-like protein and assessment of its aggregation propensity via coarse grained simulations
2026 O. Ben Mariem, L. Coppi, E. De Fabiani, I. Eberini, M. Crestani
Antigen binding triggers long-range conformational changes in monoclonal antibodies
2026 D. Bianchi, S. Saporiti, W. Palinsky, O. Ben Mariem, M. Rossi, I. Eberini, F. Centola
Sodium Ions Affect GPR17 Conformational States and Functionality
2026 L. Palazzolo, S. Daniele, D. Bianchi, L. Russo, S. Capaldi, M.L. Trincavelli, I. Eberini
In silico investigation of mAbs conformational changes upon antigen binding: impact of glycosylation and light chain isotype
2025 D. Bianchi, O. Ben Mariem, L. Palazzolo, U. Guerrini, F. Centola, M. Rossi, S. Saporiti, I. Eberini
Benchmarking and Consensus Ranking of Inverse Folding Models for Protein-Ligand Interface Design
2025 Y. Wei, U. Guerrini, I. Eberini
Structural Insights into CYP3A4–P-gp Interactions and Their Role in Personalized Autoimmune Drug Therapy
2025 Y. Wei, U. Guerrini, I. Eberini
Correlation Between CYP1A2 Genetic Polymorphism and Drug Response
2025 Y. Wei, U. Guerrini, I. Eberini